Title : Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status.

Pub. Date : 2001 Oct

PMID : 11560871






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Diltiazem cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 The aim of this study was to assess the effect of diltiazem, a CYP3A4 inhibitor, on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Diltiazem cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 Inhibition of CYP3A4 by a concomitant substrate drug like diltiazem may cause a pharmacokinetic interaction with diazepam irrespective of CYP2C19 genotype status, but whether this interaction would reflect a pharmacodynamic change of diazepam remains unconfirmed by our study. Diltiazem cytochrome P450 family 3 subfamily A member 4 Homo sapiens